Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective
ALIMENTARY PHARMACOLOGY & THERAPEUTICS. Bd. 61. H. 9. 2025 S. 1467-1478
Erscheinungsjahr: 2025
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Younossi, Zobair M. (Autor)
Razavi, Homie (Autor)
Sherman, Michael (Autor)
Allen, Alina M. (Autor)
Anstee, Quentin M. (Autor)
Cusi, Kenneth (Autor)
Friedman, Scott L. (Autor)
Lawitz, Eric (Autor)
Lazarus, Jeffrey V. (Autor)
Schuppan, Detlef (Autor)
Romero-Gomez, Manuel (Autor)
Schattenberg, Joern M. (Autor)
Vos, Miriam B. (Autor)
Wong, Vincent Wai-Sun (Autor)
Ratziu, Vlad (Autor)
Hompesch, Marcus (Autor)
Sanyal, Arun J. (Autor)
Loomba, Rohit (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
